Skip to main content
logo
Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Nov 6, 2025, 3:30 PM EST

Nascent Biotech Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Market Capitalization
03176612
Market Cap Growth
-85.00%338.51%13.54%-0.40%-47.12%122.34%
Enterprise Value
-3176612
Last Close Price
0.000.180.060.060.060.27

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
PS Ratio
---6.318.45-
PB Ratio
-0.10-122.36-5.53-9.39-13.40-4.16
P/OCF Ratio
---15.26--

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
EV/Sales Ratio
---6.478.52-

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Debt / Equity Ratio
-0.11-0.48-0.30--0.34-0.05
Net Debt / Equity Ratio
-0.020.97-0.170.14-0.34-0.05
Asset Turnover
---2.331.99-
Quick Ratio
0.060.460.110.120.610.00
Current Ratio
0.310.680.160.140.610.00
Return on Assets (ROA)
-854.34%-345.34%-747.66%-66.68%-231.96%-3199.30%
Return on Capital Employed (ROCE)
406.90%868.80%166.30%68.10%296.40%119.90%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Earnings Yield
-3712.12%-6.65%-39.11%-7.46%-15.14%-33.43%
Buyback Yield / Dilution
-30.53%-31.35%-10.05%-48.93%-110.34%-14.30%